HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors.

Abstract
Resistance against currently used antitubercular therapeutics increasingly undermines efforts to contain the worldwide tuberculosis (TB) epidemic. Recently, benzothiazinone (BTZ) inhibitors have shown nanomolar potency against both drug-susceptible and multidrug-resistant strains of the tubercle bacillus. However, their proposed mode of action is lacking structural evidence. We report here the crystal structure of the BTZ target, FAD-containing oxidoreductase Mycobacterium tuberculosis DprE1, which is essential for viability. Different crystal forms of ligand-free DprE1 reveal considerable levels of structural flexibility of two surface loops that seem to govern accessibility of the active site. Structures of complexes with the BTZ-derived nitroso derivative CT325 reveal the mode of inhibitor binding, which includes a covalent link to conserved Cys387, and reveal a trifluoromethyl group as a second key determinant of interaction with the enzyme. Surprisingly, we find that a noncovalent complex was formed between DprE1 and CT319, which is structurally identical to CT325 except for an inert nitro group replacing the reactive nitroso group. This demonstrates that binding of BTZ-class inhibitors to DprE1 is not strictly dependent on formation of the covalent link to Cys387. On the basis of the structural and activity data, we propose that the complex of DrpE1 bound to CT325 is a representative of the BTZ-target complex. These results mark a significant step forward in the characterization of a key TB drug target.
AuthorsSarah M Batt, Talat Jabeen, Veemal Bhowruth, Lee Quill, Peter A Lund, Lothar Eggeling, Luke J Alderwick, Klaus Fütterer, Gurdyal S Besra
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 109 Issue 28 Pg. 11354-9 (Jul 10 2012) ISSN: 1091-6490 [Electronic] United States
PMID22733761 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Benzamides
  • Enzyme Inhibitors
  • Ligands
  • Arabinose
  • Oxidoreductases
  • Chaperonins
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Arabinose (chemistry)
  • Benzamides (pharmacology)
  • Catalytic Domain
  • Cell Wall (metabolism)
  • Chaperonins (metabolism)
  • Crystallography, X-Ray (methods)
  • Drug Resistance, Multiple
  • Enzyme Inhibitors (pharmacology)
  • Escherichia coli (metabolism)
  • Ligands
  • Models, Chemical
  • Models, Molecular
  • Molecular Conformation
  • Mycobacterium tuberculosis (metabolism)
  • Oxidoreductases (chemistry)
  • Protein Binding
  • Protein Conformation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: